Biomea Fusion Inc (BMEA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.31M
Last updated: Nov 17, 2026 at 11:04 AM ET
Biomea Fusion Inc (BMEA) Competitors
The companies most similar to Biomea Fusion are iBio, Inc. Common Stock (IBIO), ImageneBio (IMA) and Connect Biopharma Holdings (CNTB). By market cap, Biomea Fusion ranks 9th of the 13 companies on this page; MAIA Biotechnology (MAIA) is the largest at $61.75M.
Peer Comparison
BMEA's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Biomea Fusion (BMEA) | $42.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| iBio, Inc. Common Stock (IBIO) | $51.55M | N/A | 735.4x | 0.0% | N/A | 975.0% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| MAIA Biotechnology Inc. (MAIA) | $61.75M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Mereo BioPharma Group PLC ADR (MREO) | $49.11M | N/A | 61.3x | 0.0% | -116.6% | 0.0% | 0.00% |
| Pliant Therapeutics Inc (PLRX) | $43.21M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| Veru Inc (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $43.22M | 4.1x | 61.3x | 0.0% | -64.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Biomea Fusion, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| iBio, Inc. Common Stock (IBIO) | iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. | IBIO competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| MAIA Biotechnology Inc. (MAIA) | MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes... | MAIA competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Mereo BioPharma Group PLC ADR (MREO) | Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases... | MREO competitors |
| Pliant Therapeutics Inc (PLRX) | Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops... | PLRX competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| Veru Inc (VERU) | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. | VERU competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
Frequently Asked Questions About BMEA
Who are Biomea Fusion's main competitors?
The companies most similar to Biomea Fusion include iBio, Inc. Common Stock (IBIO), ImageneBio (IMA), Connect Biopharma Holdings (CNTB), MAIA Biotechnology (MAIA) and INmune Bio (INMB), listed from the closest match.
Who is Biomea Fusion's biggest competitor?
MAIA Biotechnology (MAIA) is the largest of the similar companies at $61.75M; iBio, Inc. Common Stock (IBIO) is the closest match by business profile, size, sector and industry.
How does BMEA stock compare with its competitors?
BMEA's net margin is 0.0% against a peer median of 0.0%.
Which of Biomea Fusion's competitors pays a higher dividend?
Biomea Fusion pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Biomea Fusion bigger than its competitors?
No. Biomea Fusion is 9th by market cap among the 13 companies on this page; the largest is MAIA Biotechnology (MAIA) at $61.75M.
BMEA pages: Overview, Earnings, Forecast, Financials, Competitors